Philips’ public-private partnership COMBINE-CT consortium has received a $6.5-million-euro grant ($7 million U.S.) from the Innovative Health Initiative (IHI).
The consortium will use the grant to investigate the use of CT to improve diagnosis and treatment outcomes of coronary artery disease (CAD) in Europe, according to the firm.
The goals of COMBINE-CT include increasing the use of coronary computed tomography angiography; opening data silos between hospital departments involved in the care of CAD patients; and simplifying and improving workflow for physicians, nurses, and technologists. It includes Philips, the Université Lyon 1 Claude Bernard and its affiliate entity Hospices Civils De Lyon, Instituto de Investigación Biomédica de Salamanca (IBSAL), Amsterdam UMC location AMC, University Clinic Cologne, Medical Research Infrastructure Development and Health Services Fund by the Sheba Medical Center, Cardiologie Centra Nederland, Novo Nordisk, Consorcio Centro de Investigacion Biomedica en Red M.P. & EUPATI Foundation, according to the company.
The IHI is a partnership between the European Union and industry associations, among them the European Trade Association group COCIR (medical imaging, radiotherapy, health ICT, and electromedical industries) and MedTech Europe.
